HK Stock MarketDetailed Quotes

02552 HUA MEDICINE-B

Watchlist
  • 2.240
  • +0.040+1.82%
Market Closed May 2 16:08 CST
2.36BMarket Cap-8.75P/E (TTM)

HUA MEDICINE-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
234.02%255.89M
45.97%102.66M
335.31%76.61M
--70.33M
--17.6M
----
----
----
----
----
Operating income
234.02%255.89M
45.97%102.66M
335.31%76.61M
70.33M
17.6M
Cost of sales
-234.31%-131.17M
-108.88%-54.9M
-295.92%-39.24M
---26.28M
---9.91M
----
----
----
----
----
Operating expenses
-234.31%-131.17M
-108.88%-54.9M
-295.92%-39.24M
-26.28M
-9.91M
Gross profit
233.72%124.72M
8.43%47.76M
386.07%37.37M
44.05M
7.69M
Selling expenses
-92.07%-153.18M
-15.49%-61.12M
-419.64%-79.76M
---52.92M
---15.35M
----
----
----
----
----
Administrative expenses
5.95%-116.76M
-13.11%-61.1M
4.45%-124.15M
21.18%-54.02M
3.64%-129.93M
-7.90%-68.54M
3.75%-134.84M
1.14%-63.52M
4.43%-140.08M
13.46%-64.25M
Research and development expenses
-25.39%-215.09M
-68.70%-119.78M
-32.43%-171.54M
1.78%-71M
30.67%-129.53M
26.23%-72.29M
15.44%-186.84M
12.71%-97.98M
31.36%-220.96M
32.58%-112.25M
Special items of operating profit
-11.85%118.77M
18.06%55.87M
100.27%134.74M
24.51%47.32M
59,115.79%67.28M
2,219.80%38.01M
99.59%-114K
-133.87%-1.79M
-162.76%-27.69M
-1.51%5.29M
Operating profit
-18.79%-241.54M
-59.83%-138.36M
-1.74%-203.33M
15.80%-86.57M
37.90%-199.84M
37.04%-102.81M
17.22%-321.78M
4.62%-163.29M
8.39%-388.74M
27.26%-171.21M
Financing cost
-8.88%-8.61M
-9.95%-3.88M
-115.63%-7.91M
-95.51%-3.53M
7.16%-3.67M
9.70%-1.81M
10.15%-3.95M
11.04%-2M
-384.67%-4.4M
-1,641.86%-2.25M
Earning before tax
-18.42%-250.14M
-57.88%-142.24M
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
After-tax profit from continuing operations
-18.42%-250.14M
-57.88%-142.24M
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
Earning after tax
-18.42%-250.14M
-57.88%-142.24M
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
Profit attributable to shareholders
-18.42%-250.14M
-57.88%-142.24M
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
Basic earnings per share
-13.64%-0.25
-66.67%-0.15
-4.76%-0.22
18.18%-0.09
38.24%-0.21
35.29%-0.11
17.07%-0.34
5.56%-0.17
8.89%-0.41
28.00%-0.18
Diluted earnings per share
-13.64%-0.25
-66.67%-0.15
-4.76%-0.22
18.18%-0.09
38.24%-0.21
35.29%-0.11
17.07%-0.34
5.56%-0.17
8.89%-0.41
28.00%-0.18
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover 234.02%255.89M45.97%102.66M335.31%76.61M--70.33M--17.6M--------------------
Operating income 234.02%255.89M45.97%102.66M335.31%76.61M70.33M17.6M
Cost of sales -234.31%-131.17M-108.88%-54.9M-295.92%-39.24M---26.28M---9.91M--------------------
Operating expenses -234.31%-131.17M-108.88%-54.9M-295.92%-39.24M-26.28M-9.91M
Gross profit 233.72%124.72M8.43%47.76M386.07%37.37M44.05M7.69M
Selling expenses -92.07%-153.18M-15.49%-61.12M-419.64%-79.76M---52.92M---15.35M--------------------
Administrative expenses 5.95%-116.76M-13.11%-61.1M4.45%-124.15M21.18%-54.02M3.64%-129.93M-7.90%-68.54M3.75%-134.84M1.14%-63.52M4.43%-140.08M13.46%-64.25M
Research and development expenses -25.39%-215.09M-68.70%-119.78M-32.43%-171.54M1.78%-71M30.67%-129.53M26.23%-72.29M15.44%-186.84M12.71%-97.98M31.36%-220.96M32.58%-112.25M
Special items of operating profit -11.85%118.77M18.06%55.87M100.27%134.74M24.51%47.32M59,115.79%67.28M2,219.80%38.01M99.59%-114K-133.87%-1.79M-162.76%-27.69M-1.51%5.29M
Operating profit -18.79%-241.54M-59.83%-138.36M-1.74%-203.33M15.80%-86.57M37.90%-199.84M37.04%-102.81M17.22%-321.78M4.62%-163.29M8.39%-388.74M27.26%-171.21M
Financing cost -8.88%-8.61M-9.95%-3.88M-115.63%-7.91M-95.51%-3.53M7.16%-3.67M9.70%-1.81M10.15%-3.95M11.04%-2M-384.67%-4.4M-1,641.86%-2.25M
Earning before tax -18.42%-250.14M-57.88%-142.24M-3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M
After-tax profit from continuing operations -18.42%-250.14M-57.88%-142.24M-3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M
Earning after tax -18.42%-250.14M-57.88%-142.24M-3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M
Profit attributable to shareholders -18.42%-250.14M-57.88%-142.24M-3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M
Basic earnings per share -13.64%-0.25-66.67%-0.15-4.76%-0.2218.18%-0.0938.24%-0.2135.29%-0.1117.07%-0.345.56%-0.178.89%-0.4128.00%-0.18
Diluted earnings per share -13.64%-0.25-66.67%-0.15-4.76%-0.2218.18%-0.0938.24%-0.2135.29%-0.1117.07%-0.345.56%-0.178.89%-0.4128.00%-0.18
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More